Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A for degenerative coxarthrosis
2012-004890-25Phase 3Completed
- Sponsor
- Azienda Ospedaliero-Universitaria di Udine
- Start
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hip osteoarthritis comparing Botulinum toxin type A with Placebo (2 arms). Primary endpoint: Harris Hip Score at week 4. Started Jan 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on 2012-004890-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004890-25.